BioInformant

Your Global Leader in Stem Cell Market Research

MENUMENU
  • Blog
    • Interviews
  • News
  • Stem Cells
    • iPS Cells
    • MSCs
    • HSCs
    • Adipose SCs
    • Neural Stem Cells
  • Exosomes
  • CAR-T
  • Cord Blood
  • Shop
    • Products
    • Submit PR
    • Advertise
  • About
    • Testimonials
    • Story
    • Guarantee
    • Contact
  • Home
  • Blog
    • Stem Cells
      • HSCs
      • iPS Cells
      • MSCs
      • Neural Stem Cells
      • Adipose SCs
    • Exosomes
    • Cell Therapy
      • CAR-T
    • Cord Blood
    • Stem Cell News
    • Interviews
  • COVID-19
  • Shop
  • Submit PR
  • Company
    • Advertise
    • Testimonials
    • Story
    • Job Posts
    • Guarantee
    • Privacy Policy
    • Contact
Home » Celltex

What Stem Cell Clinics Do You Trust?

January 11, 2022 By Cade Hildreth (CEO) 11 Comments

Feature | What Stem Cell Clinics Do You Trust?

This article explores leading stem cell centers within the U.S. and worldwide. Read on to learn about this emerging area of medicine. [Read more…]

Filed Under: Adipose SCs, HSCs, MSCs, Stem Cells Tagged With: Celltex, GIOSTAR, Okyanos, Regenexx, Stem Cell Institute

Celltex Therapeutics | Interview with CEO David Eller

August 29, 2017 By Cade Hildreth (CEO) Leave a Comment

David Eller Celltex

David Eller CelltexCelltex Therapeutics is a regenerative medicine company that specializes in banking autologous mesenchymal stem cells (MSCs) for therapeutic use. In the Celltex procedure, a small fat sample is taken, from which MSCs are extracted, isolated, multiplied and stored for future use. Patients can then use these autologous (“self-derived”) stem cells for regenerative purposes through infusions or injections performed by a licensed physician.

In this article: 

  • Introduction to Celltex Therapeutics
  • Interview with CEO David Eller
  • Background of Celltex Therapeutics
  • Celltex Treatment Approach
  • History of Celltex Therapeutics
  • Celltex and the FDA
  • Celltex’s Facility in Cancun, Mexico
  • Celltex Growth and Expansion
  • Celltex 5-Year Goals [Read more…]

Filed Under: MSCs Tagged With: cell therapy, Celltex, fda

This Week in Stem Cells – Trends, Trials, and “Tell All” Interviews

December 24, 2016 By Cade Hildreth (CEO) Leave a Comment

This Week in Stem Cells

Happy Holidays! I hope you are enjoying this exciting season with family, friends, colleagues, and lots of holiday cheer. As you celebrate and reflect on a prosperous 2016, we have posted new stem cell industry coverage to help you prepare for 2017. This week in stem cells we cover cell therapy in Asia, exosomes going exponential, a massive $225M series A financing, and much more. [Read more…]

Filed Under: iPS Cells, MSCs, Neural Stem Cells Tagged With: cell therapy, Celltex, exosomes, International Stem Cell Corporation, investors

Nanocellect

Marathon Products

Let’s Get Social

  • Facebook
  • Twitter
  • LinkedIn
  • Pinterest
  • Instagram
Menu
  • Blog
  • Stem Cell News
    • Press Releases
  • Stem Cells
    • HSCs
    • iPS Cells
    • MSCs
    • Neural Stem Cells
    • Adipose SCs
  • Exosomes
  • Cell Therapy
    • CAR-T
  • Cord Blood
  • Interviews

Cart

Top Rated Products

  • Job Posting on BioInformant Job Posting on BioInformant.com - Your Perfect Hire Is In Our Audience
    تم التقييم 0 من 5
    $297
  • U.S. Cord Blood Banking Survey Cord Blood Banking Survey of U.S. Parents [2017]
    تم التقييم 0 من 5
    $197
  • Exosome Companies 2020 Global Database of Exosome Companies
    تم التقييم 0 من 5
    $149 $97
My Tweets

BioInformant's World-Class Clients

  • Submit Press Release
  • Advertise
  • Privacy and Terms

Copyright © 2022 · BIOINFORMANT, Your Global Leader in Stem Cell Market Research

| Email: Info@BioInformant.com | Phone: 703-859-7617 |

800 Corporate Drive, Suite 301, Stafford, VA 22554, United States

Disclaimer: All statements made on this website are NOT expressed as medical claims or advice. They are not intended to diagnose, treat, cure or prevent any disease or condition. If you have a health condition or concern, consult your physician or health care provider.